Emerging regulation and function of betatrophin

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 23640-23657

  Tseng, Yi Hsin ^a   Yeh, Yung Hsin ^b   Chen, Wei Jan ^b   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ANGPTL8; Betatrophin; C19orf80; Chromosome 19 open reading frame 80; Insulin and lipid; Irisin; Lipasin; RIFL; TD26; Thyroid hormone

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALPHA INTERFERON; ANGIOPOIETIN LIKE PROTEIN 3; APOLIPOPROTEIN B; BETATROPHIN; CYCLIN A1; FATTY ACID SYNTHASE; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTONE DEACETYLASE; INSULIN; IRISIN; KI 67 ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MESSENGER RNA; PERILIPIN; PROTEIN; THYROID HORMONE; TRANSCRIPTION FACTOR E2F2; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

AUTOPHAGY; CALORIC INTAKE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DIABETES MELLITUS; ENERGY EXPENDITURE; GENE; GENE STRUCTURE; GESTATION PERIOD; HORMONAL REGULATION; HUMAN; MURINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; OBESITY; PANCREAS CELL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN MOTIF; REGULATORY MECHANISM; REVIEW; SECRETION (PROCESS); SEQUENCE ALIGNMENT; THERMOGENESIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS;

MAMMALIA; MURINAE;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE HORMONES;

EID: 84919784570     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151223640     Document Type: Review

References (72)

1. Dong, X.Y.; Pang, X.W.; Yu, S.T.; Su, Y.R.; Wang, H.C.; Yin, Y.H.; Wang, Y.D.; Chen, W.F. Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int. J. Cancer 2004, 112, 239-248.
2. Quagliarini, F.; Wang, Y.; Kozlitina, J.; Grishin, N.V.; Hyde, R.; Boerwinkle, E.; Valenzuela, D.M.; Murphy, A.J.; Cohen, J.C.; Hobbs, H.H. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc. Natl. Acad. Sci. USA 2012, 109, 19751-19756.
3. Ren, G.; Kim, J.Y.; Smas, C.M. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 2012, 303, E334-E351.
4. Zhang, R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem. Biophys. Res. Commun. 2012, 424, 786-792.
5. Yi, P.; Park, J.S.; Melton, D.A. Betatrophin: A hormone that controls pancreatic β-cell proliferation. Cell 2013, 153, 747-758.
6. Teslovich, T.M.; Musunuru, K.; Smith, A.V.; Edmondson, A.C.; Stylianou, I.M.; Koseki, M.; Pirruccello, J.P.; Ripatti, S.; Chasman, D.I.; Willer, C.J. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466, 707-713.
7. Weissglas-Volkov, D.; Aguilar-Salinas, C.A.; Nikkola, E.; Deere, K.A.; Cruz-Bautista, I.; Arellano-Campos, O.; Munoz-Hernandez, L.L.; Gomez-Munguia, L.; Ordonez-Sanchez, M.L.; Reddy, P.M., et al. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J. Med. Genet. 2013, 50, 298-308.
8. Yu, P.; Ma, D.; Xu, M. Nested genes in the human genome. Genomics 2005, 86, 414-422.
9. Fu, Z.; Yao, F.; Abou-Samra, A.B.; Zhang, R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem. Biophys. Res. Commun. 2013, 430, 1126-1131.
10. Clark, H.F.; Gurney, A.L.; Abaya, E.; Baker, K.; Baldwin, D.; Brush, J.; Chen, J.; Chow, B.; Chui, C.; Crowley, C., et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment. Genome Res. 2003, 13, 2265-2270.
11. Tseng, Y.H.; Ke, P.Y.; Liao, C.J.; Wu, S.M.; Chi, H.C.; Tsai, C.Y.; Chen, C.Y.; Lin, Y.H.; Lin, K.H. Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism. Autophagy 2014, 10, 20-31.
12. Fenzl, A.; Itariu, B.K.; Kosi, L.; Fritzer-Szekeres, M.; Kautzky-Willer, A.; Stulnig, T.M.; Kiefer, F.W. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014, 57, 1204-1208.
13. Espes, D.; Lau, J.; Carlsson, P.O. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014, 57, 50-53.
14. Fu, Z.; Berhane, F.; Fite, A.; Seyoum, B.; Abou-Samra, A.B.; Zhang, R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci. Rep. 2014, 4, 5013.
15. Wang, Y.; Quagliarini, F.; Gusarova, V.; Gromada, J.; Valenzuela, D.M.; Cohen, J.C.; Hobbs, H.H. Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc. Natl. Acad. Sci. USA 2013, 110, 16109-16114.
16. Espes, D.; Martinell, M.; Carlsson, P.O. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int. J. Endocrinol. 2014, 2014, 323407.
17. Fu, Z.; Abou-Samra, A.B.; Zhang, R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia 2014, 57, 2232-2234.
18. Hu, H.; Sun, W.; Yu, S.; Hong, X.; Qian, W.; Tang, B.; Wang, D.; Yang, L.; Wang, J.; Mao, C., et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014, 37, 2718-2722.
19. Gomez-Ambrosi, J.; Pascual, E.; Catalan, V.; Rodriguez, A.; Ramirez, B.; Silva, C.; Gil, M.J.; Salvador, J.; Fruhbeck, G. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J. Clin. Endocrinol. Metab. 2014, doi:org/10.1210/jc.2014-1568.
20. Franck, N.; Gummesson, A.; Jernas, M.; Glad, C.; Svensson, P.A.; Guillot, G.; Rudemo, M.; Nystrom, F.H.; Carlsson, L.M.; Olsson, B. Identification of adipocyte genes regulated by caloric intake. J. Clin. Endocrinol. Metab. 2011, 96, E413-E418.
21. Zhang, Y.; Li, R.; Meng, Y.; Li, S.; Donelan, W.; Zhao, Y.; Qi, L.; Zhang, M.; Wang, X.; Cui, T., et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2013, 63, 514-525.
22. Saito, S.; Ojima, H.; Ichikawa, H.; Hirohashi, S.; Kondo, T. Molecular background of α-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Sci. 2008, 99, 2402-2409.
23. Ammerpohl, O.; Pratschke, J.; Schafmayer, C.; Haake, A.; Faber, W.; von Kampen, O.; Brosch, M.; Sipos, B.; von Schonfels, W.; Balschun, K., et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer 2011, 130, 1319-1928.
24. Schaffer, L.; Brand, C.L.; Hansen, B.F.; Ribel, U.; Shaw, A.C.; Slaaby, R.; Sturis, J. A novel high-affinity peptide antagonist to the insulin receptor. Biochem. Biophys. Res. Commun. 2008, 376, 380-383.
25. Knudsen, L.; Hansen, B.F.; Jensen, P.; Pedersen, T.A.; Vestergaard, K.; Schaffer, L.; Blagoev, B.; Oleksiewicz, M.B.; Kiselyov, V.V.; de Meyts, P. Agonism and antagonism at the insulin receptor. PLoS One 2012, 7, e51972.
26. Vikram, A.; Jena, G. S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. Biochem. Biophys. Res. Commun. 2010, 398, 260-265.
27. Karnik, S.K.; Chen, H.; McLean, G.W.; Heit, J.J.; Gu, X.; Zhang, A.Y.; Fontaine, M.; Yen, M.H.; Kim, S.K. Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007, 318, 806-809.
28. Sweeney, T.R.; Moser, A.H.; Shigenaga, J.K.; Grunfeld, C.; Feingold, K.R. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E1313-E1320.
29. Mazurkiewicz, J.C.; Watts, G.F.; Warburton, F.G.; Slavin, B.M.; Lowy, C.; Koukkou, E. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J. Clin. Pathol. 1994, 47, 728-731.
30. Belo, L.; Caslake, M.; Gaffney, D.; Santos-Silva, A.; Pereira-Leite, L.; Quintanilha, A.; Rebelo, I. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002, 162, 425-432.
31. Sattar, N.; Greer, I.A.; Louden, J.; Lindsay, G.; McConnell, M.; Shepherd, J.; Packard, C.J. Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J. Clin. Endocrinol. Metab. 1997, 82, 2483-2491.
32. Witztum, J.L. Susceptibility of low-density lipoprotein to oxidative modification. Am. J. Med. 1993, 94, 347-349.
33. Cheng, S.Y. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev. Endocr. Metab. Disord. 2000, 1, 9-18.
34. Yen, P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81, 1097-1142.
35. Hashimoto, K.; Mori, M. Crosstalk of thyroid hormone receptor and liver X receptor in lipid metabolism and beyond. Endocr. J. 2011, 58, 921-930.
36. Duntas, L.H. Thyroid disease and lipids. Thyroid 2002, 12, 287-293.
37. Mullur, R.; Liu, Y.Y.; Brent, G.A. Thyroid hormone regulation of metabolism. Physiol. Rev. 2014, 94, 355-382.
38. Muller, M.J.; Seitz, H.J. Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo-and hyperthyroidism. Klin. Wochenschr. 1984, 62, 49-55.
39. Blennemann, B.; Leahy, P.; Kim, T.S.; Freake, H.C. Tissue-specific regulation of lipogenic mRNAs by thyroid hormone. Mol. Cell. Endocrinol. 1995, 110, 1-8.
40. Hashimoto, K.; Matsumoto, S.; Yamada, M.; Satoh, T.; Mori, M. Liver X receptor-α gene expression is positively regulated by thyroid hormone. Endocrinology 2007, 148, 4667-4675.
41. Hansson, P.; Valdemarsson, S.; Nilsson-Ehle, P. Experimental hyperthyroidism in man: Effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase. Horm. Metab. Res. 1983, 15, 449-452.
42. Ness, G.C.; Pendleton, L.C.; Li, Y.C.; Chiang, J.Y. Effect of thyroid hormone on hepatic cholesterol 7α hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats. Biochem. Biophys. Res. Commun. 1990, 172, 1150-1156.
43. Pandak, W.M.; Heuman, D.M.; Redford, K.; Stravitz, R.T.; Chiang, J.Y.; Hylemon, P.B.; Vlahcevic, Z.R. Hormonal regulation of cholesterol 7α-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat. J. Lipid Res. 1997, 38, 2483-2491.
44. Keyes, W.G.; Wilcox, H.G.; Heimberg, M. Formation of the very low density lipoprotein and metabolism of [1-14C]-oleate by perfused livers from rats treated with triiodothyronine or propylthiouracil. Metabolism 1981, 30, 135-146.
45. Laker, M.E.; Mayes, P.A. Effect of hyperthyroidism and hypothyroidism on lipid and carbohydrate metabolism of the perfused rat liver. Biochem. J. 1981, 196, 247-255.
46. Gupta, B.B.; Chakrabarty, P. Effects of thyroidal, gonadal and adrenal hormones on tissue respiration of streaked frog, Rana limnocharis, at low temperature. Indian J. Exp. Biol. 1990, 28, 23-26.
47. Muller, M.J.; Seitz, H.J. Thyroid hormone action on intermediary metabolism. Part I: Respiration, thermogenesis and carbohydrate metabolism. Klin. Wochenschr. 1984, 62, 11-18.
48. Silva, J.E. The thermogenic effect of thyroid hormone and its clinical implications. Ann. Intern. Med. 2003, 139, 205-213.
49. Weirich, R.T.; Schwartz, H.L.; Oppenheimer, J.H. An analysis of the interrelationship of nuclear and plasma triiodothyronine in the sea lamprey, lake trout, and rat: Evolutionary considerations. Endocrinology 1987, 120, 664-677.
50. Huotari, J.; Helenius, A. Endosome maturation. EMBO J. 2011, 30, 3481-3500.
51. Bostrom, P.; Wu, J.; Jedrychowski, M.P.; Korde, A.; Ye, L.; Lo, J.C.; Rasbach, K.A.; Bostrom, E.A.; Choi, J.H.; Long, J.Z., et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481, 463-468.
52. Sundin, U.; Mills, I.; Fain, J.N. Thyroid-catecholamine interactions in isolated rat brown adipocytes. Metabolism 1984, 33, 1028-1033.
53. Oike, Y.; Akao, M.; Kubota, Y.; Suda, T. Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy. Trends Mol. Med. 2005, 11, 473-479.
54. Zhang, R.; Abou-Samra, A.B. Emerging roles of lipasin as a critical lipid regulator. Biochem. Biophys. Res. Commun. 2013, 432, 401-405.
55. Fugier, C.; Tousaint, J.J.; Prieur, X.; Plateroti, M.; Samarut, J.; Delerive, P. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J. Biol. Chem. 2006, 281, 11553-11559.
56. Chittur, S.V.; Sangster-Guity, N.; McCormick, P.J. Histone deacetylase inhibitors: A new mode for inhibition of cholesterol metabolism. BMC Genomics 2008, 9, 507.
57. Lanford, R.E.; Guerra, B.; Lee, H.; Chavez, D.; Brasky, K.M.; Bigger, C.B. Genomic response to interferon-α in chimpanzees: Implications of rapid down-regulation for hepatitis C kinetics. Hepatology 2006, 43, 961-972.
58. Nguyen, H.; Sankaran, S.; Dandekar, S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology 2006, 354, 58-68.
59. Sawada, H.; Takami, K.; Asahi, S. A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol. Sci. 2005, 83, 282-292.
60. Czaja, M.J. Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 2011, 140, 1895-1908.
61. Morselli, E.; Maiuri, M.C.; Markaki, M.; Megalou, E.; Pasparaki, A.; Palikaras, K.; Criollo, A.; Galluzzi, L.; Malik, S.A.; Vitale, I., et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010, 1, e10.
62. Andreo, U.; Guo, L.; Chirieac, D.V.; Tuyama, A.C.; Montenont, E.; Brodsky, J.L.; Fisher, E.A. Insulin-stimulated degradation of apolipoprotein B100: Roles of class II phosphatidylinositol-3-kinase and autophagy. PLoS One 2013, 8, e57590.
63. He, C.; Bassik, M.C.; Moresi, V.; Sun, K.; Wei, Y.; Zou, Z.; An, Z.; Loh, J.; Fisher, J.; Sun, Q., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481, 511-515.
64. Irrcher, I.; Adhihetty, P.J.; Sheehan, T.; Joseph, A.M.; Hood, D.A. PPARγ coactivator-1α expression during thyroid hormone-and contractile activity-induced mitochondrial adaptations. Am. J. Physiol. Cell Physiol. 2003, 284, C1669-C1677.
65. Leone, T.C.; Lehman, J.J.; Finck, B.N.; Schaeffer, P.J.; Wende, A.R.; Boudina, S.; Courtois, M.; Wozniak, D.F.; Sambandam, N.; Bernal-Mizrachi, C., et al. PGC-1α deficiency causes multi-system energy metabolic derangements: Muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005, 3, e101.
66. Lu, S.; Xu, D. Cold stress accentuates pressure overload-induced cardiac hypertrophy and contractile dysfunction: Role of TRPV1/AMPK-mediated autophagy. Biochem. Biophys. Res. Commun. 2013, 442, 8-15.
67. Ke, P.Y.; Chen, S.S. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Investig. 2011, 121, 37-56.
68. Morissette, G.; Moreau, E.; Gaudreault, R.; Marceau, F. Massive cell vacuolization induced by organic amines such as procainamide. J. Pharmacol. Exp. Ther. 2004, 310, 395-406.
69. Virgin, H.W.; Levine, B. Autophagy genes in immunity. Nat. Immunol. 2009, 10, 461-470.
70. Cao, D.J.; Wang, Z.V.; Battiprolu, P.K.; Jiang, N.; Morales, C.R.; Kong, Y.; Rothermel, B.A.; Gillette, T.G.; Hill, J.A. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. USA 2011, 108, 4123-4128.
71. Jiao, Y.; Le Lay, J.; Yu, M.; Naji, A.; Kaestner, K.H. Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes 2014, 63, 1283-1288.
72. Stewart, A.F. Betatrophin versus bitter-trophin and the elephant in the room: Time for a new normal in β-cell regeneration research. Diabetes 2014, 63, 1198-1199.